SmartEndo

AI-powered early risk screening tool for endometriosis.

SmartEndo is an evidence-based, artificial intelligence–enabled digital health application designed for early risk assessment of endometriosis in women, particularly in low-resource settings.
Endometriosis is a chronic gynecological condition affecting approximately 1 in 10 women globally, often associated with delayed diagnosis, chronic pelvic pain, infertility, and reduced quality of life. SmartEndo addresses this gap by providing a non-invasive, accessible, and scalable screening solution.

Key Features:

AI-Powered Risk Assessment: SmartEndo utilizes a clinically validated algorithm to generate individualized risk scores based on structured symptom and history inputs.
Bilingual and Culturally Adapted Interface: Designed for usability in Bangladesh and similar contexts, supporting both English and Bangla language.
Decision Support for Early Triage: Facilitates timely referral of patients who require further gynecological evaluation.

Intended Use:
Women experiencing menstrual or pelvic symptoms
Early screening in community and clinical settings
Supporting healthcare providers in triage decisions
Disclaimer:

SmartEndo is a screening and decision-support tool only. It does not provide a definitive diagnosis of endometriosis. Users are advised to consult qualified healthcare professionals for clinical evaluation and management.